Aquestive Therapeutics AQST
NASDAQ AQST
$4.47 +0.03 (+0.59%)
As of: Oct 2, 2026 · 1:33 PM EDT

Aquestive Therapeutics (AQST) Cash from Financing Activities (2017 - 2026)

Updated

Aquestive Therapeutics (AQST) reported Cash from Financing Activities of -$2.59 million for Q2 2026, compared with -$100,000 a year earlier.

Analysis

Aquestive Therapeutics (AQST) Cash from Financing Activities (2017 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Aquestive Therapeutics' Cash from Financing Activities came in at $83.9 million, up 305.6% year-over-year; for FY2025, it was $102.62 million, up 22.8% from FY2024.

  • Cash from Financing Activities has a five-year compound annual growth rate of 29.2% (FY2020 to FY2025).
  • By year, Cash from Financing Activities came in at $83.59 million in FY2024, $3.97 million in FY2023 (-65.7%), $11.59 million in FY2022 (-61.5%) and $30.11 million in FY2021 (+5.8%).
  • The Q2 2026 figure ranks as the lowest quarterly Cash from Financing Activities since Q1 2023.
  • Year over year, Cash from Financing Activities gained in 1 of the last four quarters, with growth averaging 17.8%.
  • The high point for year-over-year Cash from Financing Activities in five years was Q4 2025 (growth of 320.4%); the low point was Q4 2024 (a decline of 96.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $4.42 million (Q1 2026), $660,000 (Q4 2025) and $81.41 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Aquestive Therapeutics 581.12 Mn 121.66 Mn 9.80 Mn -2.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.59 Mn
Mar 31, 2026 4.42 Mn
Dec 31, 2025 660,000.00
Sep 30, 2025 81.41 Mn
Jun 30, 2025 -100,000.00
Mar 31, 2025 20.65 Mn
Dec 31, 2024 157,000.00
Sep 30, 2024 -17,000.00
Jun 30, 2024 1.71 Mn
Mar 31, 2024 81.74 Mn
Dec 31, 2023 3.91 Mn
Sep 30, 2023 4.98 Mn
Jun 30, 2023 4.29 Mn
Mar 31, 2023 -9.21 Mn
Dec 31, 2022 234,000.00
Sep 30, 2022 -138,000.00
Jun 30, 2022 10.20 Mn
Mar 31, 2022 1.30 Mn
Dec 31, 2021 5.45 Mn
Sep 30, 2021 6.08 Mn
API Access

Aquestive Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=AQST&period=max&api_key=YOUR_API_KEY